Inferior Vena Cava Index in Patients Undergoing Liver Resection

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

91 participants

Study Classification

OBSERVATIONAL

Study Start Date

2005-01-31

Study Completion Date

2014-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study was to evaluate whether IVC index measured intraoperatively was affected by fluid administration and could add any helpful information about the hemodynamics during hepatic resection. In addition, the investigators evaluated whether IVC index was somehow correlated with the risk of postoperative complication.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Assessment of Ultrasonographic Measurement of Inferior Vena Cava Collapsibility Index in Prediction of Hypotension Associated With Tourniquet Release in Total Knee Replacement Surgeries Under Spinal Anesthesia

NCT05076929

Fluid Hypovolemia, Cerebrospinal

COMPLETED

Assess the Potential of the IVC Distensibility Index as a Predictor of Postoperative Fluid Status in Children.

NCT06957171

Intraoperative Fluid Volume Inferior Vena Cava Diameter

COMPLETED

Ultrasound of the Inferior Vena Cava in the Prevention of Hypotension After Induction of General Anesthesia

NCT06530901

Elderly Patients Undergoing Elective Non-cardiac Surgery

NOT_YET_RECRUITING

The Ability Of Inferior Vena Caval Distensibility Index With Passive Leg Raising Test To Predict Spinal Anesthesia-induced Hypotension In Elderly Patients Undergoing Infra-umbilical Surgeries. A Prospective Observational Study.

NCT05991063

Spinal Anesthetics Causing Adverse Effects in Therapeutic Use

UNKNOWN

Infrahepatic Inferior Vena Cava Clamping During Hepatectomy

NCT00732979

Hemorrhage

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Liver Neoplasms

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients with liver tumors candidate to hepatectomy

IVC diameters evaluation by intraoperative ultrasound

Intervention Type OTHER

Out of consecutive patients who underwent hepatectomy for primary and secondary liver tumors, patients in whom IVC diameters were intraoperatively measured for clinical reasons were retrospectively selected and analyzed

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

IVC diameters evaluation by intraoperative ultrasound

Out of consecutive patients who underwent hepatectomy for primary and secondary liver tumors, patients in whom IVC diameters were intraoperatively measured for clinical reasons were retrospectively selected and analyzed

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Patients who underwent hepatectomy for primary and secondary liver tumors

Exclusion Criteria

Patients with tumoral thrombosis or full tumoral involvement/compression of IVC were excluded. Patients unresectable at laparotomy for any extra-hepatic or intrahepatic reason and patients previously submitted to hepatectomy were not included

Minimum Eligible Age

34 Years

Maximum Eligible Age

85 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No